Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 281, Issue 1-2, 2009, Pages 34-40

  Watanabe, Akihiro ^a   Matsushita, Takuya ^a   Doi, Hikaru ^a   Matsuoka, Takashi ^a   Shigeto, Hiroshi ^a   Isobe, Noriko ^a   Kawano, Yuji ^a   Tobimatsu, Shozo ^a   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti aquaporin 4 antibody; Motor evoked potential; Multiple sclerosis; Neuromyelitis optica; Opticospinal form; Sensory evoked potential; Visual evoked potential

Indexed keywords

AQUAPORIN 4 ANTIBODY; BETA INTERFERON; CORTICOSTEROID; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARM WEAKNESS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OPTIC NERVE LESION; PLASMAPHERESIS; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; RECURRENT DISEASE; SENSORY NERVE CONDUCTION; SEROLOGY; VISION; VISUAL IMPAIRMENT;

ADULT; AQUAPORIN 4; ARM; AUTOANTIBODIES; EVOKED POTENTIALS; EVOKED POTENTIALS, MOTOR; EVOKED POTENTIALS, SOMATOSENSORY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; LEG; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEURAL CONDUCTION; OPTIC NERVE;

EID: 67349097416     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.02.371     Document Type: Article

References (34)

1. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2 (2003) 117-127
2. Kira J., Kanai T., Nishimura Y., Yamasaki K., Matsushita S., Kawano Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40 (1996) 569-574
3. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 (1999) 1107-1114
4. Cree B.A., Goodin D.S., and Hauser S.L. Neuromyelitis optica. Semin Neurol 22 (2002) 105-122
5. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 (2002) 1450-1461
6. Yamasaki K., Horiuchi I., Minohara M., Kawano Y., Ohyagi Y., Yamada T., et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122 (1999) 1689-1696
7. Ishizu T., Osoegawa M., Mei F.J., Kikuchi H., Tanaka M., Takakura Y., et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128 (2005) 988-1002
8. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
9. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
10. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
11. Nakashima I., Fujihara K., Miyazawa I., Misu T., Narikawa K., Nakamura M., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77 (2006) 1073-1075
12. Matsuoka T., Matsushita T., Kawano Y., Osoegawa M., Ochi H., Ishizu T., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130 (2007) 1206-1223
13. Weinshenker B.G., Wingerchuk D.M., Nakashima I., Fujihara K., and Lennon V.A. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5 (2006) 110-111
14. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., et al. Pattern specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica. Brain 130 (2007) 1194-1205
15. Misu T., Fujihara K., Kakita A., Konno H., Nakamura M., Watanabe S., et al. Loss of aquaporin-4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130 (2007) 1224-1234
16. Jacob A., Matiello M., Wingerchuk D.M., Lucchinetti C.F., Pittock S.J., and Weinshenker B.G. Neuromyelitis optica: changing concepts. J Neuroimmunol 187 (2007) 126-138
17. Chong H.T., Ramli N., Lee K.H., Kim B.J., Ursekar M., Dayananda K., et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Can J Neurol Sci 33 (2006) 95-100
18. Su J.J., Osoegawa M., Matsuoka T., Monihara M., Tanaka M., Ishizu T., et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 243 (2006) 21-30
19. Minohara M., Matsuoka T., Li W., Osoegawa M., Ishizu T., Ohyagi Y., et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 178 (2006) 156-160
20. Matsuoka T., Matsushita T., Osoegawa M., Ochi H., Kawano Y., Mihara F., et al. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266 (2008) 115-125
21. Bot J.C., Barkhof F., Polman C.H., Lycklama à Nijeholt G.J., de Groot V., Bergers E., et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62 (2004) 226-233
22. Tanaka K., Tani T., Tanaka M., Saida T., Idezuka J., Yamazaki M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 13 (2007) 850-855
23. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
24. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
25. Tobimatsu S., Fukui R., Kato M., Kobayashi T., and Kuroiwa Y. Multimodality evoked potentials in patients and carriers with adrenoleukodystrophy and adrenomyeloneuropathy. Electroencephalogr Clin Neurophysiol 62 (1985) 18-144
26. Pineda A.A., Ogata K., Osoegawa M., Murai H., Shigeto H., Yoshiura T., et al. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy. J Neurol Sci 255 (2007) 1-6
27. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6 (2000) 159-163
28. Papadopoulos M.C., Manley G.T., Krishna S., and Verkman A.S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18 (2004) 1291-1293
29. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69 (2007) 2221-2231
30. Tao H., Ma Z., Dai P., and Jiang L. Computer-aided three-dimensional reconstruction and measurement of the optic canal and intracanalicular structures. Laryngoscope 109 (1999) 1499-1502
31. Thale A., Jungmann K., and Paulsen F. Morphologic studies of the optic canal. Orbit 21 (2002) 131-137
32. Cerovski B., Sikic J., Juri J., and Petrovic J. The role of visual evoked potentials in the diagnosis of optic nerve injury as a result of mild head trauma. Coll Antropol 25 (2001) 47-55 [Suppl]
33. Girotto J.A., Gamble W.B., Robertson B., Redett R., Muehlberger T., Mayer M., et al. Blindness after reduction of facial fractures. Plast Reconstr Surg 102 (1998) 1821-1834
34. Acheson J.F. Optic nerve disorders: role of canal and nerve sheath decompression surgery. Eye 18 (2004) 1169-1174